SARS-CoV-2 3CLpro-IN-2

• CAT Number: I043673
• CAS Number: 2765088-93-3
• Molecular Formula: C21H18F5N5O4
• Molecular Weight: 499.39
• Purity: ≥95%
• Synonyms: 2-[4-[4-(difluoromethoxy)-2-methylanilino]-2,6-dioxo-3-[(3,4,5-trifluorophenyl)methyl]-1,3,5-triazin-1-yl]-N-methylacetamide
• InChI: InChI=1S/C21H18F5N5O4/c1-10-5-12(35-18(25)26)3-4-15(10)28-19-29-20(33)31(9-16(32)27-2)21(34)30(19)8-11-6-13(22)17(24)14(23)7-11/h3-7,18H,8-9H2,1-2H3,(H,27,32)(H,28,29,33)
• InChIKey: JHDIUUFGPILEJO-UHFFFAOYSA-N
• SMILES: CC1=C(C=CC(=C1)OC(F)F)NC2=NC(=O)N(C(=O)N2CC3=CC(=C(C(=C3)F)F)F)CC(=O)NC

SARS-CoV-2 3CLpro-IN-2（Cat No.:I043673）is a small molecule inhibitor designed to target the 3CL protease (3CLpro) of the SARS-CoV-2 virus. The 3CLpro enzyme is essential for viral replication, as it cleaves viral polyproteins into functional units required for the virus’s lifecycle. By inhibiting 3CLpro, this compound disrupts the viral replication process, preventing the virus from replicating within host cells. SARS-CoV-2 3CLpro-IN-2 holds significant potential as a therapeutic agent for treating COVID-19, offering a targeted approach to limit viral spread and alleviate symptoms by blocking key viral functions.